ATPC vs. TOI, CORBF, DCGO, XGN, EUDA, SERA, NAKA, KDLY, QIPT, and OPGN
Should you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Oncology Institute (TOI), Global Cord Blood (CORBF), DocGo (DCGO), Exagen (XGN), EUDA Health (EUDA), Sera Prognostics (SERA), KindlyMD (NAKA), Kindly MD (KDLY), Quipt Home Medical (QIPT), and OpGen (OPGN). These companies are all part of the "healthcare" industry.
Agape ATP vs. Its Competitors
Oncology Institute (NASDAQ:TOI) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.
In the previous week, Oncology Institute had 1 more articles in the media than Agape ATP. MarketBeat recorded 1 mentions for Oncology Institute and 0 mentions for Agape ATP. Oncology Institute's average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score.
Agape ATP has lower revenue, but higher earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than Agape ATP, indicating that it is currently the more affordable of the two stocks.
36.9% of Oncology Institute shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 8.5% of Oncology Institute shares are held by company insiders. Comparatively, 9.7% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Oncology Institute has a net margin of -15.38% compared to Agape ATP's net margin of -191.34%. Agape ATP's return on equity of -30.95% beat Oncology Institute's return on equity.
Oncology Institute has a beta of 0.02, meaning that its share price is 98% less volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.98, meaning that its share price is 198% less volatile than the S&P 500.
Oncology Institute currently has a consensus price target of $7.00, suggesting a potential upside of 180.00%. Given Oncology Institute's stronger consensus rating and higher possible upside, research analysts clearly believe Oncology Institute is more favorable than Agape ATP.
Summary
Oncology Institute beats Agape ATP on 8 of the 15 factors compared between the two stocks.
Get Agape ATP News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Agape ATP Competitors List
Related Companies and Tools
This page (NASDAQ:ATPC) was last updated on 7/8/2025 by MarketBeat.com Staff
